November 2, 2016
GE Healthcare, Valneva join forces to create cell culture medium for vaccine
GE Healthcare and Valneva have joined forces to create cell culture medium for vaccine
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
November 2, 2016
Abzena, Gilead drop Chron Disease drug after Phase II study
Abzena has issued a statement in which it notes that during the conference call to accompany Gilead Sciences Inc.’s (‘Gilead’) announcement of third quarter
November 2, 2016
Targovax CEO steps down, current CFO takes the role
Targovax CEO has stepped down, current CFO takes the role
November 2, 2016
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
European Patent Office OKs new patent for Allergy Therapeutics’ Microcrystalline Tyrosine tech
November 2, 2016
India’s Ajanta gets green light for its high blood pressure generic
Ajanta Pharma has gotten US FDA’s approval to launch its high blood pressure tablets Amlodipine
November 2, 2016
Shire doubles third quarter revenues, operates with net loss in Q3
Shire doubles third quarter revenues, operates with net loss in Q3
November 2, 2016
India’s Koanna gets UK’s MHRA OK for Imatinib tablets
India’s Koanna gets marketing approval from MHRA for Imatinib tablets
November 2, 2016
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
November 1, 2016
Pfizer to discontinue two ongoing cardiovascular studies
Pfizer announced today the discontinuation of the global clinical development program for bococizumab…
November 1, 2016
Allergan closes down Tobira purchace
Allergan has completed the acquisition of Tobira Therapeutics